Dr. Joan Torras is responsible for the primary renal diseases in the Nephrology Department at Bellvitge Hospital and is Aggregate Professor at the University of Barcelona Medicine College. He is a specialist in Fabry disease, taking care of 22 patients with this condition over 20 years. He has more than 30 years of expertise in experimental and translational studies and has led several clinical trials. His main research fields comprise: pathophysiology of ischemia-reperfusion in naive or allograft models; setting the experimental transplantation model; gene therapy using hHGF electroporation and MSC infusion; CD40 gene silencing; experimental lupus nephritis; models of population pharmacokinetics in CMV prophylaxis-therapy; evaluation of the cellular allo-response in human renal transplantation using ELISPOT; study of ELISPOT as a new biomarker in autoimmune diseases such as membranous nephropathy or ANCA vasculitis; biomarkers in ATIN in experimental and clinics; development of a new dual costimulatory fusion protein.